Could a cancer drug help kids with rare fat-loss disease and diabetes?
NCT ID NCT03936829
First seen Mar 26, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study looks at whether cyclophosphamide, a drug that calms the immune system, can help people with a rare condition that causes fat loss (lipodystrophy) and type 1 diabetes. The goal is to see if it lowers the amount of insulin needed each day. Ten people are taking part, and the study is no longer recruiting new participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.